Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.09 USD | -1.42% | +10.00% | +12.37% |
Mar. 28 | Pulmatrix, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 13 | Pulmatrix, Inc. Approves Termination of Margaret Wasilewski as Chief Medical Officer | CI |
Business Summary
Number of employees: 22
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Novel Class of Inhaled Therapeutic Products
100.0
%
| 6 | 100.0 % | 7 | 100.0 % | +20.21% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 6 | 100.0 % | 7 | 100.0 % | +20.21% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Teofilo Raad
CEO | Chief Executive Officer | 54 | 17-05-02 |
Peter Ludlum
DFI | Director of Finance/CFO | 68 | 22-04-17 |
Aidan Curran
CTO | Chief Tech/Sci/R&D Officer | - | 14-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Richard Batycky
BRD | Director/Board Member | 56 | 19-10-31 |
Director/Board Member | 54 | 20-06-22 | |
Todd Bazemore
BRD | Director/Board Member | 53 | 20-09-30 |
Anand Varadan
BRD | Director/Board Member | 57 | 21-07-25 |
Teofilo Raad
CEO | Chief Executive Officer | 54 | 17-05-02 |
Michael Higgins
CHM | Chairman | 61 | 15-06-14 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 3,652,285 | 3,652,260 ( 100.00 %) | 0 | 100.00 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+12.37% | 7.74M | |
-3.30% | 102B | |
+3.46% | 96.09B | |
-1.02% | 22.05B | |
-18.32% | 20.81B | |
-6.87% | 19.06B | |
-40.70% | 16.05B | |
-26.46% | 14.01B | |
+1.48% | 13.38B | |
+22.92% | 11.01B |
- Stock Market
- Equities
- PULM Stock
- Company Pulmatrix, Inc.